Alzheimer s & Dementia · 2024 · 32 citations · 35 references
Life SciencesNeurologyNeuroscienceMolecular NeurobiologyMolecular NeuroscienceNeurodegenerationAlzheimer DiseaseBiomarkers Of NeurodegenerationDementia BiomarkersDementia Risk FactorsNeurodegenerative DiseasesNeurodegenerative DisordersAlzheimer Disease ProgressionAmyloid Beta PlaquesAmyloid Pathology ModelsAmyloid PlaquesDisease Trajectory AssessmentHumanized Mouse ModelsNeurofilament PathologyTransgenic Mouse Models
INTRODUCTION: MODEL-AD (Model Organism Development and Evaluation for Late-Onset Alzheimer's Disease) is creating and distributing novel mouse models with humanized, clinically relevant genetic risk factors to capture the trajectory and progression of late-onset Alzheimer's disease (LOAD) more accurately. METHODS: We created the LOAD2 model by combining apolipoprotein E4 (APOE4), Trem2*R47H, and humanized amyloid-beta (Aβ). Mice were subjected to a control diet or a high-fat/high-sugar diet (LOAD2+HFD). We assessed disease-relevant outcome measures in plasma and brain including neuroinflammation, Aβ, neurodegeneration, neuroimaging, and multi-omics. RESULTS: By 18 months, LOAD2+HFD mice exhibited sex-specific neuron loss, elevated insoluble brain Aβ42, increased plasma neurofilament light chain (NfL), and altered gene/protein expression related to lipid metabolism and synaptic function. Imaging showed reductions in brain volume and neurovascular uncoupling. Deficits in acquiring touchscreen-based cognitive tasks were observed. DISCUSSION: The comprehensive characterization of LOAD2+HFD mice reveals that this model is important for preclinical studies seeking to understand disease trajectory and progression of LOAD prior to or independent of amyloid plaques and tau tangles. HIGHLIGHTS: By 18 months, unlike control mice (e.g., LOAD2 mice fed a control diet, CD), LOAD2+HFD mice presented subtle but significant loss of neurons in the cortex, elevated levels of insoluble Ab42 in the brain, and increased plasma neurofilament light chain (NfL). Transcriptomics and proteomics showed changes in gene/proteins relating to a variety of disease-relevant processes including lipid metabolism and synaptic function. In vivo imaging revealed an age-dependent reduction in brain region volume (MRI) and neurovascular uncoupling (PET/CT). LOAD2+HFD mice also demonstrated deficits in acquisition of touchscreen-based cognitive tasks.
35
WGCNA: an R package for weighted correlation network analysis
Peter Langfelder, Steve Horvath · BMC Bioinformatics · 2008 · 29.1K citations · Full text
Holly D. Oakley, Sarah L. Cole, Sreemathi Logan et al. · Journal of Neuroscience · 2006 · 3.6K citations · Full text
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yasumasa Yoshiyama, Makoto Higuchi, Bin Zhang et al. · Neuron · 2007 · 2.3K citations · Full text
Single App knock-in mouse models of Alzheimer's disease
Takashi Saito, Yukio Matsuba, Naomi Mihira et al. · Nature Neuroscience · 2014 · 1.4K citations
Apolipoprotein E controls cerebrovascular integrity via cyclophilin A
Robert D. Bell, Ethan A. Winkler, Itender Singh et al. · Nature · 2012 · 1.3K citations · Full text